SCHOLAR ROCK HOLDING CORPORATION Earnings Per Share (Basic)
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Earnings Per Share (Basic) of -$0.84 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for the quarter ending 2026-06-30 was -$0.84.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for the quarter ending 2026-03-31 was -$0.83.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for the quarter ending 2025-12-31 was -$0.76.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for the quarter ending 2025-09-30 was -$0.90.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for fiscal 2025 was -$3.29.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for fiscal 2024 was -$2.47.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for fiscal 2023 was -$1.99.
- SCHOLAR ROCK HOLDING CORPORATION earnings per share, basic for fiscal 2022 was -$2.26.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.84 10-Q · filed 2026-08-06 | -$1.67 10-Q · filed 2026-08-06 | -$2.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.32 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.83 10-Q · filed 2026-05-07 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.45 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.65 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.62 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.29 10-K · filed 2026-03-03 |
| 2025-09-30 | -$0.90 10-Q · filed 2025-11-14 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.54 10-Q · filed 2025-11-14 | -$3.15 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.98 10-Q · filed 2026-08-06 | -$1.65 10-Q · filed 2026-08-06 | -$2.25 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.67 10-Q · filed 2026-05-07 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.54 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.47 10-K · filed 2026-03-03 |
| 2024-09-30 | -$0.66 10-Q · filed 2025-11-14 | -$1.27 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$1.86 10-Q · filed 2025-11-14 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-06-30 | -$0.60 10-Q · filed 2025-08-06 | -$1.20 10-Q · filed 2025-08-06 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.23 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-03-31 | -$0.59 10-Q · filed 2025-05-14 | -$1.09 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.62 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.99 10-K · filed 2025-02-27 |
| 2023-09-30 | -$0.53 10-Q · filed 2024-11-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.49 10-Q · filed 2024-11-12 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.47 10-Q · filed 2024-08-08 | -$0.97 10-Q · filed 2024-08-08 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.01 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-03-31 | -$0.49 10-Q · filed 2024-05-07 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.53 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.37 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2022-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.04 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.89 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$2.26 10-K · filed 2024-03-19 |
| 2022-09-30 | -$0.55 10-Q · filed 2023-11-07 | -$1.44 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.80 10-Q · filed 2023-11-07 | -$2.68 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$1.06 10-Q · filed 2023-08-09 | -$1.31 10-Q · filed 2023-08-09 | -$2.27 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$3.28 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-03-31 | -$0.21 10-Q · filed 2023-05-09 | -$1.18 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.19 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$3.03 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2021-12-31 | -$0.97 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$1.99 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$2.83 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$3.59 10-K · filed 2023-03-07 |
| 2021-09-30 | -$1.02 10-Q · filed 2022-11-14 | -$1.86 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$2.62 10-Q · filed 2022-11-14 | -$3.41 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$0.84 10-Q · filed 2022-08-08 | -$1.60 10-Q · filed 2022-08-08 | -$2.38 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$3.18 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-03-31 | -$0.76 10-Q · filed 2022-05-16 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$2.33 derived: net income ÷ weighted average shares · filed 2022-11-14 | |
| 2020-12-31 | -$0.78 derived: net income ÷ weighted average shares · filed 2022-03-07 | -$1.57 derived: net income ÷ weighted average shares · filed 2022-03-07 | -$2.81 10-K · filed 2022-03-07 | |
| 2020-09-30 | -$0.79 10-Q · filed 2021-11-09 | -$2.02 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |